Total Payments
$1,293
2024 Payments
$71.83
Companies
9
Transactions
50
Medicare Patients
3,597
Medicare Billing
$763,496
Payment Breakdown by Category
Food & Beverage$982.63 (76.0%)
Education$199.90 (15.5%)
Gifts$90.00 (7.0%)
Other$20.00 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $982.63 | 46 | 76.0% |
| Education | $199.90 | 2 | 15.5% |
| Gift | $90.00 | 1 | 7.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $439.01 | 16 | $0 (2019) |
| ABBVIE INC. | $390.58 | 11 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $215.00 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $100.33 | 8 | $0 (2023) |
| Takeda Pharmaceuticals America, Inc. | $70.04 | 9 | $0 (2017) |
| Madrigal Pharmaceuticals | $25.89 | 1 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $23.74 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $15.13 | 1 | $0 (2022) |
| Medtronic, Inc. | $12.81 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $71.83 | 3 | ABBVIE INC. ($45.94) |
| 2023 | $28.75 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($28.75) |
| 2022 | $281.53 | 6 | ABBVIE INC. ($253.59) |
| 2019 | $108.29 | 6 | Janssen Biotech, Inc. ($81.24) |
| 2018 | $217.36 | 15 | Janssen Biotech, Inc. ($119.92) |
| 2017 | $584.77 | 19 | Janssen Biotech, Inc. ($237.85) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: LIVER DISEASE | ||||||
| 10/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/11/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $122.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/29/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.13 | General |
| 04/05/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $114.99 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2022 | Medtronic, Inc. | BARRX (Device) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Ablation | ||||||
| 01/13/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: IMMUNOLOGY | ||||||
| 01/13/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Immunology | ||||||
| 05/07/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Immunology | ||||||
| 04/17/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Immunology | ||||||
| 03/01/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Lower GI | ||||||
| 02/27/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Immunology | ||||||
| 01/30/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Immunology | ||||||
| 10/24/2018 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 10/24/2018 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: Immunology | ||||||
| 10/03/2018 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Immunology | ||||||
| 05/10/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Lower GI | ||||||
| 05/09/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Lower GI | ||||||
| 05/02/2018 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Immunology | ||||||
| 04/18/2018 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Immunology | ||||||
| 04/04/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Immunology | ||||||
| 02/16/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: Lower GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 830 | 10,608 | $664,422 | $240,676 |
| 2022 | 18 | 1,016 | 9,584 | $682,441 | $234,213 |
| 2021 | 19 | 936 | 8,553 | $638,431 | $218,762 |
| 2020 | 15 | 815 | 1,002 | $262,131 | $69,845 |
Total Patients
3,597
Total Services
29,747
Medicare Billing
$763,496
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 21 | 8,700 | $217,500 | $151,193 | 69.5% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 11 | 970 | $145,500 | $25,704 | 17.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 87 | 87 | $81,063 | $16,316 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 103 | $19,125 | $8,773 | 45.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 55 | $20,540 | $7,334 | 35.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 77 | 109 | $18,695 | $6,706 | 35.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 76 | 78 | $51,039 | $5,623 | 11.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $8,105 | $3,559 | 43.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 35 | $13,623 | $3,504 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 61 | $7,995 | $3,406 | 42.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $39,568 | $1,581 | 4.0% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $8,052 | $1,536 | 19.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 23 | 31 | $6,200 | $1,484 | 23.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 18 | $8,010 | $1,432 | 17.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $7,437 | $1,183 | 15.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 46 | $460.00 | $378.00 | 82.2% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 85 | 87 | $6,525 | $343.12 | 5.3% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 14 | 18 | $2,250 | $328.20 | 14.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 11 | $385.00 | $248.05 | 64.4% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 36 | 94 | $2,350 | $44.55 | 1.9% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 18 | 7,200 | $180,000 | $124,657 | 69.3% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 13 | 1,200 | $180,000 | $34,934 | 19.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 96 | 97 | $88,756 | $17,559 | 19.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 70 | 72 | $21,960 | $10,945 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 117 | $21,645 | $10,270 | 47.4% |
About Jonathan Barsa
Jonathan Barsa is a Internal Medicine healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2011. The National Provider Identifier (NPI) number assigned to this provider is 1134428907.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Barsa has received a total of $1,293 in payments from pharmaceutical and medical device companies, with $71.83 received in 2024. These payments were reported across 50 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($982.63).
As a Medicare-enrolled provider, Barsa has provided services to 3,597 Medicare beneficiaries, totaling 29,747 services with total Medicare billing of $763,496. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Albany, NY
- Active Since 03/19/2011
- Last Updated 06/20/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134428907
Products in Payments
- STELARA (Biological) $239.11
- REMICADE (Biological) $199.90
- RINVOQ (Biological) $140.93
- Entyvio (Biological) $130.24
- RELISTOR (Drug) $125.00
- SKYRIZI (Biological) $122.70
- Mavyret (Drug) $41.67
- Humira (Biological) $34.89
- GATTEX (Drug) $28.75
- RESMETIROM (Drug) $25.89
- CRE WIREGUIDED BALLOON DILATOR (Device) $23.74
- CREON (Drug) $20.00
- HUMIRA (Biological) $15.90
- BARRX (Device) $12.81
- Amitiza (Drug) $11.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Albany
Dr. Scott Beegle, M.d, M.D
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Frank Cortazar, Md, MD
Internal Medicine — Payments: $225,694
Internal Medicine $225,694
Jill Braverman-Panza, Md, MD
Internal Medicine — Payments: $176,760
Internal Medicine $176,760
Ann Michalek, Md, MD
Internal Medicine — Payments: $79,945
Internal Medicine $79,945
Dr. Nathaniel Steiger, M.d, M.D
Internal Medicine — Payments: $28,637
Internal Medicine $28,637
Mandeep Sidhu, M.d.-M.b.a, M.D.-M.B.A
Internal Medicine — Payments: $21,249
Internal Medicine $21,249